Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-8.1x3.87x-0.2x3.46x-6.29x-5.94x-.--% 2.08B
18.01x2.31x11.18x4.08x9.6x11.2x0.51% 75.96B
22.6x3.52x1.16x4.92x14.3x17.64x0.66% 49.03B
34.65x7.13x0.64x11.83x22.52x26.34x-.--% 47.88B
-55.88x2.57x0.45x3.27x9.66x11.27x3.28% 43.39B
36.73x1.64x-0.98x3.35x12.01x13.8x-.--% 30.8B
52.85x4.05x-0.81x3.32x25.76x22.9x-.--% 24.45B
-6.39x3.9x-0.34x8.72x-5.63x-5.25x-.--% 22.75B
63.73x5.54x0.43x6.02x41.43x47.86x-.--% 19.24B
22.87x3.36x0.02x4.93x12.83x17.84x-.--% 15.87B
-35.61x-6.38x0.88x17.14x-46.89x-53.7x-.--% 16.04B
58.09x23.69x0.55x35.22x49.81x51.37x0.16% 13.02B
17.76x - 0.2x3.64x14.08x16.45x-.--% 11.74B
-101.62x11177.97x2.33x10.98x-78.61x-108.5x-.--% 10.92B
41.73x - 4.38x - - - -.--% 9.61B
12.81x1.19x0.39x1.89x7.61x10.37x2.74% 7.03B
-63.42x - -2.81x - - - - 6.24B
29.22x - 1.43x7.87x20.88x24.94x0.35% 6.17B
-117.47x - 7.78x - - - -.--% 5.72B
58.17x6.99x0.85x5.65x31.28x42.13x-.--% 5.93B
Average 4.04x 749.42x 1.38x 8.02x 7.90x 8.28x 0.41% 21.19B
Weighted average by Cap. 11.31x 321.30x 2.46x 7.05x 10.83x 11.97x 0.57%
Biopharmaceuticals